| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K/A | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Retail and Mass Transit Ticketing | | | | 16.6 | 15.8 | 14.6 | 0.0 | |
| Petroleum | | | | 5.3 | 5.1 | 4.1 | 0.0 | |
| Other | | | | | | | 0.0 | |
| Other | | | | | | | 18.5 | |
| Total revenues [+] | 14.9 | 12.7 | 10.6 | 21.9 | 20.9 | 18.8 | 18.5 | 5.8 |
| Products | 13.3 | 11.4 | | | | | 12.5 | 17.3 |
| License and services | | | | | | | 6.0 | 5.8 |
| Revenue growth [+] | 16.7% | 19.7% | -51.3% | 4.8% | 11.3% | 1.5% | 219.8% | 20.3% |
| Retail and Mass Transit Ticketing | | | | 5.5% | 7.7% | 127006.9% | | |
| Petroleum | | | | 2.6% | 24.2% | 93880.8% | | |
| Cost of goods sold [+] | 21.7 | 7.6 | 6.4 | 10.7 | 10.5 | 9.5 | 18.8 | 12.0 |
| Cost of product sales | | | | | | | 8.9 | |
| Cost of licensing | | | | | | 0.3 | 0.3 | |
| Gross profit | -6.9 | 5.1 | 4.2 | 11.2 | 10.4 | 9.2 | -0.3 | -6.2 |
| Gross margin | -46.2% | 40.0% | 39.9% | 51.0% | 49.9% | 49.2% | -1.6% | -107.9% |
| Selling, general and administrative [+] | 6.5 | 6.5 | 6.4 | 9.9 | 9.3 | 9.0 | 10.9 | 8.2 |
| Sales and marketing | 2.9 | 3.2 | 2.9 | 5.9 | 5.6 | 5.5 | 6.4 | 8.2 |
| General and administrative | 3.4 | 3.0 | 3.4 | 4.0 | 3.7 | 3.5 | 4.5 | |
| Other selling, general and administrative | 0.2 | 0.2 | | | | | | |
| Research and development | 3.7 | 3.5 | 3.3 | 3.2 | 3.3 | 2.8 | 3.4 | |
| Other operating expenses | -11.1 | -0.2 | -0.3 | 0.0 | 0.1 | 0.2 | -7.8 | -4.8 |
| EBITDA [+] | -5.6 | -4.3 | -4.7 | -0.6 | -1.0 | -1.6 | -5.6 | -8.3 |
| EBITDA growth | 31.2% | -8.5% | 635.5% | -37.3% | -37.1% | -71.1% | -33.3% | 29.9% |
| EBITDA margin | -37.6% | -33.4% | -43.7% | -2.9% | -4.8% | -8.6% | -30.1% | -144.5% |
| Depreciation | 0.2 | 0.2 | 0.2 | 1.1 | 1.0 | 1.1 | 1.2 | 1.3 |
| EBITA | -5.8 | -4.5 | -4.9 | -1.7 | -2.0 | -2.7 | -6.8 | -9.7 |
| EBITA margin | -39.1% | -35.3% | -46.0% | -8.0% | -9.6% | -14.3% | -36.7% | -167.1% |
| Amortization of intangibles | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | | |
| EBIT [+] | -6.0 | -4.7 | -5.1 | -2.0 | -2.2 | -2.8 | -6.8 | -9.7 |
| EBIT growth | 27.5% | -8.2% | 159.9% | -10.1% | -21.5% | -59.1% | -29.7% | 26.4% |
| EBIT margin | -40.1% | -36.7% | -47.9% | -9.0% | -10.5% | -14.8% | -36.7% | -167.1% |
| Non-recurring items | | | | | | | | 1.0 |
| Interest income | | | 0.3 | 0.0 | 0.1 | 0.2 | 0.9 | |
| Interest income | | | 0.3 | 0.0 | 0.1 | 0.2 | 0.9 | |
| Other income (expense), net [+] | -4.1 | -0.4 | -0.7 | -0.3 | -0.4 | -0.6 | -1.5 | 0.6 |
| Litigation settlement | | | | | | 0.0 | 0.8 | |
| Other non-ooperating expenses | | | | -0.2 | -0.3 | -0.4 | -0.6 | |
| Other | -4.1 | -0.4 | -0.3 | -0.2 | -0.3 | -0.4 | -0.6 | -0.6 |
| Pre-tax income | -10.1 | -5.1 | -5.5 | -2.2 | -2.5 | -3.2 | -7.4 | -10.1 |
| Income taxes | 1.5 | 1.0 | -0.1 | -0.3 | -0.1 | -0.1 | 0.1 | 0.1 |
| Tax rate | | | 1.9% | 13.8% | 5.5% | 4.1% | | |
| Minority interest | | | | | | 0.0 | -0.1 | |
| Earnings from continuing ops | -10.2 | -5.1 | -5.3 | -1.9 | -2.4 | -6.1 | -14.9 | -10.2 |
| Earnings from discontinued ops | 0.1 | 0.1 | 0.2 | | | 2.2 | 0.3 | 0.3 |
| Net income | -10.1 | -5.0 | -5.9 | -0.3 | -0.6 | -3.9 | -14.6 | -9.9 |
| Net margin | -67.8% | -39.6% | -55.3% | -1.2% | -2.9% | -20.6% | -79.3% | -171.1% |
| |
| Basic EPS [+] | ($0.16) | ($0.09) | ($0.13) | ($0.05) | ($0.06) | ($0.15) | ($0.36) | ($0.30) |
| Growth | 70.4% | -29.1% | 182.3% | -21.1% | -60.8% | -59.4% | 21.6% | 41.4% |
| Diluted EPS [+] | ($0.16) | ($0.09) | ($0.13) | ($0.05) | ($0.06) | ($0.15) | ($0.36) | ($0.30) |
| Growth | 70.4% | -29.1% | 182.3% | -21.1% | -60.8% | -59.4% | 21.6% | 41.4% |
| |
| Shares outstanding (basic) [+] | 65.6 | 55.7 | 41.4 | 41.3 | 41.1 | 40.9 | 40.9 | 34.0 |
| Growth | 17.8% | 34.5% | 0.3% | 0.4% | 0.5% | 0.1% | 20.2% | 4.1% |
| Shares outstanding (diluted) [+] | 65.6 | 55.7 | 41.4 | 41.3 | 41.1 | 40.9 | 40.9 | 34.0 |
| Growth | 17.8% | 34.5% | 0.3% | 0.4% | 0.5% | 0.1% | 20.2% | 4.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |